Patients with coronary microvascular dysfunction (CMVD) have a poor prognosis. At present, Chinese experts agree that CMVD is divided into CMVD without obstructive coronary artery disease, CMVD with obstructive coronary artery disease, and other types of CMVD. The studies of the first category is deeper and more evidence-based. This paper reviews the new progress in the management of CMVD without obstructive coronary artery disease.